Neuropathologic evidence of endothelial changes in cerebral small vessel disease
暂无分享,去创建一个
J. Williams | M. Esiri | H. Markus | R. Kalaria | L. Bridges | A. Hainsworth | K. Elderfield | Nadim S. Jiwa | Jonathan H. Williams | N. Jiwa | H. Markus | M.O. Giwa | J. Williams | M. O. Giwa
[1] R. Rouhl,et al. Endothelial Activation in Lacunar Stroke Subtypes , 2010, Stroke.
[2] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[3] J. Lowe,et al. Death‐associated protein kinase (DAPK1) in cerebral cortex of late‐onset Alzheimer's disease patients and aged controls , 2010, Neuropathology and applied neurobiology.
[4] M. Dichgans,et al. CADASIL , 2009, The Lancet Neurology.
[5] D. Lambrechts,et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. , 2009, The New England journal of medicine.
[6] J. Slade,et al. Neuropathological Correlates of Temporal Pole White Matter Hyperintensities in CADASIL , 2009, Stroke.
[7] Paul K Crane,et al. Different patterns of cerebral injury in dementia with or without diabetes. , 2009, Archives of neurology.
[8] H. Markus,et al. Do in vivo Experimental Models Reflect Human Cerebral Small Vessel Disease? a Systematic Review , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] J. Kril,et al. Neuropathologic correlates of white matter hyperintensities , 2008, Neurology.
[10] Bruce M Psaty,et al. Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study , 2008, Stroke.
[11] P. Hordijk,et al. Endothelial signaling by Ig-like cell adhesion molecules. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[12] N. Aoki,et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial , 2007, Journal of thrombosis and haemostasis : JTH.
[13] M. Zaletel,et al. Influence of Atorvastatin Treatment on l-Arginine Cerebrovascular Reactivity and Flow-Mediated Dilatation in Patients With Lacunar Infarctions , 2006, Stroke.
[14] JanjaPretnar-Oblak,et al. Influence of Atorvastatin Treatment on l-Arginine Cerebrovascular Reactivity and Flow-Mediated Dilatation in Patients With Lacunar Infarctions , 2006 .
[15] M. Viitanen,et al. Arterioles of the Lenticular Nucleus in CADASIL , 2006, Stroke.
[16] S. Black,et al. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.
[17] J. O'Brien,et al. White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury , 2006, Stroke.
[18] G. Lammie,et al. Hypertensive cerebral small vessel disease and stroke. , 2006, Brain pathology.
[19] C. Enzinger,et al. Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities: Longitudinal Results of the Austrian Stroke Prevention Study , 2005, Stroke.
[20] Tan Xiao-mei,et al. CADASIL , 2005 .
[21] D. Collen,et al. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[22] J. Olivot,et al. Soluble Thrombomodulin and Brain Infarction: Case–Control and Prospective Study , 2004, Stroke.
[23] P. Sandercock,et al. Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.
[24] Hugh S Markus,et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. , 2003, Brain : a journal of neurology.
[25] P. Hellings,et al. The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways , 2002, The Journal of experimental medicine.
[26] Alan J. Thomas,et al. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly , 2002, British Journal of Psychiatry.
[27] S. Love,et al. Expression of P‐selectin and intercellular adhesion molecule‐1 in human brain after focal infarction or cardiac arrest , 2001, Neuropathology and applied neurobiology.
[28] P. Bongrand,et al. The IL-6-Soluble IL-6Rα Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin , 2001, The Journal of Immunology.
[29] F. Rosendaal,et al. A Mutation in the Thrombomodulin Gene, 127G to A Coding for Ala25Thr, and the Risk of Myocardial Infarction in Men , 1998, Thrombosis and Haemostasis.
[30] M. Esiri,et al. Neuropathological assessment of the lesions of significance in vascular dementia , 1997, Journal of neurology, neurosurgery, and psychiatry.
[31] J. Slattery,et al. Nonhypertensive cerebral small-vessel disease. An autopsy study. , 1997, Stroke.
[32] M. Boffa,et al. Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis , 1997, Thrombosis and Haemostasis.
[33] K. Kario,et al. 'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[34] KazuomiKario,et al. ‘Silent’ Cerebral Infarction Is Associated With Hypercoagulability, Endothelial Cell Damage, and High Lp(a) Levels in Elderly Japanese , 1996 .
[35] T. Raife,et al. Cellular localization of thrombomodulin in human epithelium and squamous malignancies. , 1995, The American journal of pathology.
[36] J. Eidt,et al. Thrombomodulin activity and localization. , 1993, The International journal of developmental biology.
[37] M. Fisher,et al. Regional distribution of thrombomodulin in human brain , 1991, Brain Research.
[38] S. Yamamoto,et al. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. , 1990, Blood.
[39] R. Agati,et al. Leukoaraiosis and dementia. , 1990, Stroke.
[40] B. Weichman. Inflammation: basic principles and clinical correlates , 1988, Agents and Actions.
[41] T. Yoshimine,et al. Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains , 2005, Journal of Neuro-Oncology.
[42] R. Kalaria,et al. Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects , 2004, Acta Neuropathologica.
[43] Neurological Disorders. National Institute of Neurological Disorders and Stroke FIVE-YEAR STRATEGIC PLAN ON MINORITY HEALTH DISPARITIES , 2002 .
[44] R. Hausmann,et al. The time course of the vascular response to human brain injury – an immunohistochemical study , 2000, International Journal of Legal Medicine.
[45] C. Bell,et al. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. , 1986, Blood.